Your browser doesn't support javascript.
loading
Prospective pilot trial with combination of propranolol with chemotherapy in patients with epithelial ovarian cancer and evaluation on circulating immune cell gene expression.
Ramondetta, Lois M; Hu, Wei; Thaker, Premal H; Urbauer, Diana L; Chisholm, Gary B; Westin, Shannon N; Sun, Yunjie; Ramirez, Pedro T; Fleming, Nicole; Sahai, Sunil K; Nick, Alpa M; Arevalo, Jesusa M G; Dizon, Thomas; Coleman, Robert L; Cole, Steve W; Sood, Anil K.
Affiliation
  • Ramondetta LM; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America. Electronic address: lramonde@mdanderson.org.
  • Hu W; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Thaker PH; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Washington University School of Medicine, St. Louis, MO, United States of America.
  • Urbauer DL; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Chisholm GB; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Westin SN; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Sun Y; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Ramirez PT; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Fleming N; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Sahai SK; Department of General Internal Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Nick AM; St. Thomas Medical Partners, Gynecologic Oncology, Nashville, TN, United States of America; The University of Tennessee Health Sciences Center, Memphis, TN, United States of America.
  • Arevalo JMG; Department of Psychiatry and Biobehavioral Sciences and Medicine, University of California, Los Angeles, CA, United States of America.
  • Dizon T; Department of Psychiatry and Biobehavioral Sciences and Medicine, University of California, Los Angeles, CA, United States of America.
  • Coleman RL; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
  • Cole SW; Department of Psychiatry and Biobehavioral Sciences and Medicine, University of California, Los Angeles, CA, United States of America.
  • Sood AK; Department of Gynecologic Oncology and Reproductive Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, United States of America.
Gynecol Oncol ; 154(3): 524-530, 2019 09.
Article in En | MEDLINE | ID: mdl-31353053

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Propranolol / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Ovarian Epithelial Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Propranolol / Antineoplastic Combined Chemotherapy Protocols / Carcinoma, Ovarian Epithelial Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Middle aged Language: En Journal: Gynecol Oncol Year: 2019 Type: Article